Manufacturing Chemist provides updates on all areas of the pharma supply chain, including in-depth technical articles, market analysis, and expert insights shaping the industry. The publication offers global industry news and deep dives into key topics, making it an essential read for anyone working within or connecting to the global pharmaceutical market.
In the April 2020 issue of Manufacturing Chemist, George I’ons, Head of Product Strategy at Owen Mumford Pharmaceutical Services, examines the different factors that will impact the adoption of new biosimilars and their growing market share over original biologics. The article also discusses clinical confidence in biosimilars and the increasingly competitive drug pricing driven by greater competition.